Stem Cell Clinical Trials

The team at Cedars-Sinai Heart Institute Regenerative Medicine Clinic is dedicated to discovering new treatments for heart disease. Through innovations in stem cell usage as well as the latest technologies for treatment delivery methods, the clinicians and researchers at the clinic are always searching for new breakthroughs to provide improved heart function and better quality of life for their patients. In clinical trials, patients volunteer to receive new treatments and therapies that may one day be used in the general population.

The clinic's services cover a broad range of cardiovascular disorders including the following conditions. To learn more about current clinical trials, see below:

Myocardial Infarction

Heart Failure

(ischemic, nonischemic, postpartum)

Refractory Angina

Peripheral Arterial Disease

  • Placenta-Derived Adherent Cells in PAD Phase II (upcoming clinical trial)